Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular Carcinoma
Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular Carcinoma
Recruiting · NCT06904170 · Registry updated 2026-02-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 2 / Phase 3 | 2026-02-03 | NCT06904170 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| UNICANCER | 111 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| AP-HP Hôpital Beaujon | Clichy | France | 1 |
| AP-HP Hôpital Cochin | Paris | France | 6 |
| Centre Eugene Marquis | Rennes | France | 26 |
| Centre Georges Francois Leclerc | Dijon | France | 18 |
| Chru de Strasbourg | Strasbourg | France | 4 |
| CHU de Bordeaux | Bordeaux | France | 3 |
| CHU de Montpellier | Montpellier | France | 22 |
| Chu de Poitiers | Poitiers | France | 30 |
| CHU de Rangueil | Toulouse | France | 1 |
| CHU Hôtel-Dieu | Nantes | France | 1 |
| Hôpital Saint Joseph | Marseille | France | 4 |